Development
Vera Therapeutics, Inc.
VERA
$20.64
$0.190.93%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 159.94M | 181.02M | 197.15M | 114.65M | 114.42M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.76M | 8.19M | 6.41M | 10.22M | 9.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.92M | 1.40M | 883.00K | 823.00K | 792.00K |
| Total Current Assets | 171.62M | 190.61M | 204.45M | 125.70M | 124.98M |
|
|
|||||
| Total Current Assets | 171.62M | 190.61M | 204.45M | 125.70M | 124.98M |
| Net Property, Plant & Equipment | 3.52M | 4.07M | 4.64M | 5.22M | 5.82M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 470.00K | 465.00K | 459.00K | 455.00K | 442.00K |
| Total Assets | 175.62M | 195.18M | 209.60M | 131.44M | 131.37M |
|
|
|||||
| Total Accounts Payable | 12.30M | 13.28M | 5.33M | 11.99M | 7.01M |
| Total Accrued Expenses | 9.80M | 11.00M | 15.60M | 10.96M | 6.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.52M | 2.56M | 2.60M | 2.65M | 2.69M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 24.62M | 26.84M | 23.53M | 25.60M | 15.92M |
|
|
|||||
| Total Current Liabilities | 24.62M | 26.84M | 23.53M | 25.60M | 15.92M |
| Long-Term Debt | 25.04M | 24.96M | 24.89M | 24.81M | 4.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.96M | 2.57M | 3.19M | 3.83M | 4.48M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 286.00K | 287.00K | 286.00K | 286.00K | 286.00K |
| Total Liabilities | 51.91M | 54.66M | 51.90M | 54.53M | 25.65M |
|
|
|||||
| Common Stock & APIC | 407.23M | 404.01M | 400.89M | 290.24M | 286.67M |
| Retained Earnings | -283.45M | -263.34M | -243.18M | -213.11M | -180.67M |
| Treasury Stock & Other | -75.00K | -142.00K | -4.00K | -224.00K | -279.00K |
| Total Common Equity | 123.71M | 140.52M | 157.71M | 76.91M | 105.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 123.71M | 140.52M | 157.71M | 76.91M | 105.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 123.71M | 140.52M | 157.71M | 76.91M | 105.72M |
|
|
|||||